Wearable Devices, Inc. (NASDAQ:WLDS) is a medical technology company specializing in remote cardiac monitoring solutions. The company develops and commercializes wearable, single-patient use patches that continuously record electrocardiogram (ECG) data over extended periods. These patches integrate wirelessly with a cloud-based analytics platform, enabling clinicians to detect and diagnose arrhythmias and other cardiac conditions without the constraints of traditional Holter monitors.
The company’s flagship product portfolio includes disposable adhesive ECG monitoring patches designed for use in ambulatory settings, supported by proprietary software that applies advanced algorithms to flag irregular heart rhythms in near real time. This end-to-end system encompasses patient onboarding, data acquisition, secure transmission, and automated reporting, streamlining workflows for diagnostic labs, hospitals, and remote monitoring service providers.
Founded in the early 2010s and headquartered in Charlotte, North Carolina, Wearable Devices began as a spin-out of academic research in medical telemetry. The company received FDA clearance for its first-generation device and has since expanded its offerings to include longer-wear options suitable for up to 30 days of continuous monitoring. While its initial commercial focus is in the United States, Wearable Devices has also pursued partnerships in select international markets to address growing demand for remote cardiac care.
Underpinning its technology is a leadership team with deep expertise in cardiology, biomedical engineering, and healthcare IT. The executive management group and board of directors bring decades of combined experience in medical device development, regulatory affairs and clinical services. This cross-disciplinary team is dedicated to advancing remote patient monitoring and improving diagnostic outcomes for individuals with suspected cardiac disorders.
AI Generated. May Contain Errors.
